Answers are grounded in this paper and cite their sources.
Background: Recurrent pregnancy loss (RPL) is defined as three or more successive pregnancy loss before the completion of 20th week of gestation.The imbalance between pro angiogenic and anti angiogenic factors can lead to impaired placentation, and result in RPL.Angiopoietins 1 (ANGPT1), Fibroblast Growth Factor (FGF2), and Platelet Derived Growth Factor B (PDGFB) are potent angiogenic factors involved in different developmental processes including embryonic development.Methods: Gene expression analysis of targeted ANGPT1, FGF2, PDGFB genes and a house keeping gene GAPDH was carried out in the placental tissue collected from 35 women with unexplained recurrent pregnancy loss and compared with the placental tissue obtained from 20 women with medically terminated pregnancy.Placental tissue was collected in RNA later followed by RNA isolation, quantification, cDNA synthesis and real time qPCR using allele specific primers and SYBR green.Results: The mRNA expression of ANGPT1 gene was significantly downregulated in the placenta of recurrent pregnancy loss cases (1.96-fold, p<0.0001) in comparison to the placenta of medically terminated pregnancies.,No significant difference was observed in the placental expression of FGF2 and PDGFB genes in recurrent pregnancy loss cases and the control subjects. Conclusion:In conclusion the results of the present study suggest that altered expression of ANGPT1 gene in placenta may disturb placental angiogenesis and contribute to recurrent pregnancy loss.However, no significant difference was observed in the placental expression of FGF2 and PDGFB genes between RPL and control subjects.
No takes yet. Share an insight, caveat, or question.
Venkateshwari Ananthapur (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: